News

It's going to be 'put up or shut up' for Novo Nordisk's Wegovy this summer: Barclays' Emily Field
Emily Field, Barclacys head of European pharmaceuticals equity research, joins 'Squawk Box' to discuss Novo Nordisk's ...
Novo Nordisk cuts 2025 outlook due to compounding-hit Wegovy demand
Shares in Novo Nordisk were still up after Q1 2025 witnessed a total revenue jump by 18%, compared to Q1 2024.
Novo Nordisk Investors Breathe Sigh of Relief Despite Guidance Hit From Copycat Drugs — 2nd Update
U.S. trade policy has also heightened investor concerns over the potential impact to Novo Nordisk's key market. U.S. President Trump has threatened to unveil tariffs on pharmaceutical products in the ...
Stock market today: Dow, S&P 500, Nasdaq futures rise with US-China trade talks, Fed rate call in focus
US stock futures rose after the Trump administration announced top US officials would meet with their Chinese counterparts ...
YEN.com.gh on MSN37m
Weight-loss drugmaker Novo Nordisk slims sales forecast
Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, cut its ...